Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

Francis K.L. Chan(Chinese University of Hong Kong), Ka‐Fai To(Prince of Wales Hospital), Justin CY Wu, MY Yung(Prince of Wales Hospital), Wai K. Leung, Timothy Kwok, Yui Hui, Henry Chan, Cynthia Chan(Chinese University of Hong Kong), Elsie Hui, Jean Woo, Joseph J.�Y. Sung

The Lancet

January 1, 2002

10.1016/s0140-6736(02)07272-0

Cited by 330

Abstract

Related Papers

Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs

M. Michael Wolfe, David R. Lichtenstein, Gurkirpal Singh|New England Journal of Medicine|1999|2k

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

Sherine E. Gabriel, Liisa Jaakkimainen, Claire Bombardier|Annals of Internal Medicine|1991|1.2k

Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

Fred E. Silverstein, David Y. Graham, John R. Senior et al.|Annals of Internal Medicine|1995|1.1k

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

Peter Malfertheiner, Françis Mégraud, Colm O’Morain et al.|European Journal of Gastroenterology & Hepatology|1997|983

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

M. J. S. Langman, J Weil, Paul Wainwright et al.|The Lancet|1994|876